Mentor Capital is well poised to become a significant participant in the expanding medical sector of Cancer Immunotherapy, an emerging approach to overcome the historic medical nemesis of Cancer. This is starting with MNTR's initial $2.2 million or 20% investment in Quantum Immunologics, Inc. (QI), a private company. The QI agreement contemplates "there is potential for significantly increased investment, or even merger of the Parties." <center>For More information: <a href="http://www.mentorcapital.com/$5-Share-Sr.-Securities-Analyst.html">Visit our website</a> </center>